ÌÇÐÄvlog

This randomized clinical trial evaluates whether simvastatin has potential as a disease-modifying treatment for patients with moderate Parkinson disease.

This cross-sectional study estimates the prevalence of dementia and mild cognitive impairment in the US in 2016 by age, race, ethnicity, and sex.

This secondary analysis of a randomized clinical trial investigates the association of donanemab treatment with plasma biomarkers associated with Alzheimer disease.

This secondary analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism—Japan Large Ischemic Core Trial (RESCUE-Japan LIMIT) evaluates the safety and efficacy of endovascular therapy in patients with acute large ischemic stroke by Alberta Stroke Program Early Computed Tomography Score.

This cross-sectional study investigates if genetic diagnoses in patients with epilepsy are associated with changes in clinical management and subsequent outcomes.

This cohort study identifies participants without Alzheimer disease and other neurodegenerative pathologies and determines the extent to which cerebrovascular disease pathologies were associated with cognitive impairment.

This systematic review and meta-analysis investigates the molecular diagnostic yield of exome sequencing and chromosomal microarray in cerebral palsy.

This cohort study assesses whether the use of angiotensin receptor blocker therapy is associated with a reduced incidence of epilepsy in patients with hypertension.

This cohort study examines data from UK Biobank participants who had whole-exome sequencing to determine the frequency of pathogenic variants in the 3 most common monogenic cerebral small vessel diseases and their associations with prevalent and incident stroke and dementia.